What are the visual field deficits in optic neuritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Visual Field Defects in Optic Neuritis

The most common visual field defect in optic neuritis is central scotoma, though a wide variety of visual field defects can occur including diffuse loss, nerve fiber bundle defects (arcuate, partial arcuate, paracentral), and altitudinal defects.

Primary Visual Field Defect Patterns

Common Patterns

  • Central/Centrocecal Scotoma: Present in approximately 8-68% of optic neuritis cases 1, 2

    • Characterized by a scotoma centered on the fixation point with a sloping border
    • Highly characteristic of optic neuritis compared to other optic neuropathies 3
  • Diffuse Visual Field Loss:

    • Present in 48-66% of affected eyes during acute phase 1, 2
    • Represents generalized depression of visual sensitivity across the field
    • More common in the acute phase than in later stages
  • Nerve Fiber Bundle Defects:

    • Partial arcuate, paracentral, and complete arcuate defects
    • Become the predominant pattern during recovery and long-term follow-up 2
    • Present in approximately 35-40% of cases after the acute phase
  • Altitudinal or Other Nerve Fiber Bundle Defects:

    • Present in approximately 20% of cases 1
    • Superior altitudinal defects seen in about 13% of optic neuritis cases 3
    • Inferior altitudinal defects seen in about 8% of optic neuritis cases 3

Evolution of Visual Field Defects

  1. Acute Phase (at onset):

    • Predominantly diffuse visual field loss (66.2% of abnormalities) 2
    • Central scotoma often prominent
  2. Recovery Phase (1-15 years):

    • Shift from diffuse to localized defects
    • Nerve fiber bundle defects become predominant (35-40% of abnormalities) 2
    • Foveal threshold highly correlates with visual acuity and contrast sensitivity

Diagnostic Considerations

Differentiating Features from Other Optic Neuropathies

  • Optic Neuritis vs. Anterior Ischemic Optic Neuropathy (AION):
    • Central scotoma with sloping border is highly characteristic of optic neuritis (50% of cases) 3
    • Inferior altitudinal defect with sharp border along horizontal meridian is characteristic of AION 3
    • Visual field pattern alone has limited utility in distinguishing between conditions 1

Special Considerations in Different Etiologies

  • Multiple Sclerosis-Associated Optic Neuritis:

    • Central scotoma is present in 90% of MS-associated optic neuritis cases 4
    • Visual field examination may show central or arcuate defects 5, 6
  • Neuromyelitis Optica (NMO)-Associated Optic Neuritis:

    • Higher incidence of non-central scotoma patterns (47% of cases) 4
    • Altitudinal hemianopia is the most frequent non-central scotoma pattern
    • 13% of NMO patients may never experience central scotoma 4
    • May suggest an ischemic mechanism mediated by anti-aquaporin-4 antibody

Clinical Evaluation

  • Visual Field Testing:

    • Full-field testing is essential as restricted perimetry (30 degrees) may miss diagnostic patterns 3
    • Goldmann perimetry or standard automated perimetry can be used
    • Visual-evoked potentials can detect bilateral optic nerve damage before clinically apparent 5, 6
  • Fellow Eye Involvement:

    • Asymptomatic visual field defects in the fellow eye are common (68.8% of patients) 1
    • Evidence of chiasmal or retrochiasmal visual field defects present in 2.9% of patients 1

Prognostic Implications

  • Visual Recovery:
    • Recovery of high-contrast visual acuity is common in idiopathic and MS-associated optic neuritis 7
    • Residual deficits in contrast sensitivity, binocular vision, and motion perception may persist
    • Recovery may be poorer in patients seropositive for antibodies to myelin oligodendrocyte glycoprotein, AQP4, and CRMP5 7

Treatment Considerations

  • Acute Management:

    • High-dose intravenous methylprednisolone is recommended for optic neuritis 5, 6
    • Early treatment is essential, particularly in cases with severe visual field defects
    • Plasmapheresis may be considered in severe cases 5
  • Long-term Management:

    • Maintenance immunosuppressive therapy may be needed to prevent relapses 5
    • Anticoagulation may be considered in antiphospholipid-positive patients not responding to immunosuppressive therapy 5

Understanding the pattern of visual field defects in optic neuritis is crucial for accurate diagnosis, determining etiology, and guiding appropriate treatment to preserve visual function.

References

Research

Visual field defects in optic neuritis and anterior ischemic optic neuropathy: distinctive features.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Optic Nerve Edema Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.